Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Collaborative physical activity program for newly-diagnosed cancer patients

Official title: Impact of a Collaborative Program of Customized, Adaptive and Supervised Physical Activity on Adherence, Fitness, Quality of Life and Resilience of Newly-diagnosed Cancer Patients

Run by University Hospital, Toulouse · NCT05723471 · Data updated 2026-11-12

This study is testing whether a special exercise program can help newly-diagnosed cancer patients feel better and stick to their workouts compared to regular exercise plans.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment350 (estimated)
SponsorUniversity Hospital, Toulouse
Academic / other
Locations2 sites (Nancy, France and 1 other locations)
StatusRecruiting
StartedAugust 30, 2024
Main results expectedMay 1, 2028
Study endsDecember 31, 2028
Registry record updatedApril 10, 2025
Trial IDNCT05723471 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are newly-diagnosed cancer patients who can begin a physical activity program within the first year of their diagnosis and have a performance status between 0 to 2.

Probably not a fit

Patients with uncontrolled cardiovascular disease, severe peripheral neuropathy, or other serious health conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of a customized collaborative exercise program compared to standard exercise prescriptions for patients who have recently been diagnosed with cancer. It is a multicenter, randomized, open-label trial that aims to assess long-term adherence to physical activity and its impact on quality of life, treatment tolerance, and survival rates. Participants will be randomly assigned to either the adaptive physical activity group or the control group, with the goal of improving their overall well-being during cancer treatment.

Why it matters

Potential benefit: If successful, this program could significantly enhance the quality of life and treatment outcomes for newly-diagnosed cancer patients.

How similar studies have gone: Previous studies have shown that adaptive physical activity can improve quality of life and treatment tolerance in cancer patients, indicating a promising approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* newly-diagnosed cancer patient
* able to start a program of physical activity within the first year follow diagnosis
* performance status between 0 to 2

Exclusion Criteria:

* uncontrolled cardiovascular disease
* peripheral neuropathy grade 3-4 with risk of falling
* bone metastasis with risk of bone fracture
* platelets \<100X109/L
* hemoglobin \<8g/dL
* patient under legal protection

Where it's running

  • CHRU de Nancy
    Nancy, France, France
    Recruiting
  • Stéphanie MOTTON
    Toulouse, France, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.